This proposed study aims to conduct timely research that promotes vaccine confidence and vaccination of one strongly recommended vaccine with suboptimal uptake rates: Human papillomavirus (HPV) in vulnerable and underserved youth aged 11-14.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Percentage of eligible individuals agreeing to participate
Timeframe: T0 (occurs after consenting and before assigning to different study conditions)
Proportion of participants who are retained through follow-up
Timeframe: T2 (occurs two months after completion of the intervention)
Percentage of participants who complete the intervention and assessments
Timeframe: T2 (occurs two months after completion of the intervention)
Participant satisfaction with the project
Timeframe: T2 (occurs two months after completion of the intervention)
Intention to vaccinate the children against HPV
Timeframe: T0 (occurs after consenting and before assigning to different study conditions); T1 (occurs immediately post intervention);T2 (occurs two months after completion of the intervention)